Hanying Yi

机构：Central South University, PharmacoGenetics (China), Xiangya Hospital Central South University

发表论文 8 篇 · 总被引 168 次 · h-index 5

代表论文

• PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer (2022 · Cancer Letters · 被引 112)
• TRPV1 inhibition suppresses non-small cell lung cancer progression by inhibiting tumour growth and enhancing the immune response (2023 · Cellular Oncology · 被引 14)
• β-Adrenergic Receptor Inhibitor and Oncolytic Herpesvirus Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects on Colorectal Cancer (2021 · Frontiers in Pharmacology · 被引 14)
• ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function (2025 · Journal for ImmunoTherapy of Cancer · 被引 12)
• Propranolol suppresses bladder cancer by manipulating intracellular pH via NHE1 (2022 · Translational Andrology and Urology · 被引 8)
• Propranolol metabolite and enantiomers affect colorectal cancer development by inhibiting MAPK pathway and downregulating PD-1 expression (2025 · International Immunopharmacology · 被引 1)